SB
Sunil Bhonsle
See RemarksDirector

Sunil Bhonsle insider trades: Titan Pharmaceuticals (TTP) stock purchases

See Remarks, Titan Pharmaceuticals Last trade Sep 21, 2018 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
17
Open-market trades
since 2005
5
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sunil reports to the SEC

Open-market buys and sales

17 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 21, 2018TTP↑ Buy$75K
Jul 18, 2016TTNP↑ Buy$50K
Feb 22, 2016TTNP↑ Buy$42K
Jan 15, 2016TTNP↑ Buy$16K
Jan 11, 2016TTNP.OB↑ Buy$54K
Oct 1, 2015TTNP.OB↑ Buy$3K
Sep 28, 2015TTNP.OB↑ Buy$3K
Sep 16, 2015TTNP.OB↑ Buy$7K
Aug 25, 2015TTNP.OB↑ Buy$35K
Oct 13, 2014TTNP.OB↑ Buy$103K
Jun 18, 2013TTNP.OB↑ Buy$23K
Nov 18, 2011TTNP.OB↑ Buy$33K
Feb 11, 2008AMEX↑ Buy$25K
May 22, 2007AMEX↑ Buy$30K
May 17, 2007AMEX↑ Buy$12K
Nov 7, 2005TTP↑ Buy$43K
Nov 3, 2005TTP↑ Buy$15K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Sunil Bhonsle's insider trades

Sunil Bhonsle is See Remarks at Titan Pharmaceuticals (TTP). Since Nov 3, 2005, Sunil has reported 17 open-market purchases worth $568K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (16 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TTP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.